A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer
Clinical trial NCT04277598 · COMPLETED
Trial details
- NCT number
- NCT04277598
- Sponsor
- Aposcience AG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-09
- Primary completion
- 2023-12-06
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.